Canton Strategic Holdings (CNTN) Operating Income (2021 - 2026)
Canton Strategic Holdings (CNTN) posted Operating Income of -$36.9 million for Q1 2026, down 170.8% on a QoQ basis from -$13.6 million in Q4 2025, and down 1347.71% year-over-year from $3.0 million in Q1 2025.
Canton Strategic Holdings (CNTN) Operating Income (2021 - 2026) Analysis & Trends
Canton Strategic Holdings' Operating Income history runs 6 years deep, the most recent figure standing at -$36.9 million for Q1 2026.
- Quarterly Operating Income fell 1347.71% year-over-year to -$36.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$54.4 million (down 331.99% YoY) and the FY2025 annual result came in at -$20.1 million, down 62.15% from the prior year.
- Operating Income was -$36.9 million for Q1 2026 at Canton Strategic Holdings, down from -$13.6 million in the prior quarter.
- Across five years, Operating Income topped out at -$1.4 million in Q1 2022 and bottomed at -$36.9 million in Q1 2026.
- A 5-year average of -$5.0 million and a median of -$2.4 million in 2023 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income sank 1638.74% — and 2025, when it jumped 45.84%.
- Canton Strategic Holdings' Operating Income stood at -$1.8 million in 2022, then slumped by 43.29% to -$2.5 million in 2023, then plunged by 50.67% to -$3.8 million in 2024, then tumbled by 257.0% to -$13.6 million in 2025, then plunged by 170.8% to -$36.9 million in 2026.
- Business Quant data shows CNTN's Operating Income at -$36.9 million in Q1 2026, -$13.6 million in Q4 2025, and -$2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | -36.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.87 Mn |
| Dec 31, 2025 | -13.61 Mn |
| Sep 30, 2025 | -2.09 Mn |
| Jun 30, 2025 | -1.85 Mn |
| Mar 31, 2025 | -2.55 Mn |
| Dec 31, 2024 | -3.81 Mn |
| Sep 30, 2024 | -3.87 Mn |
| Jun 30, 2024 | -2.37 Mn |
| Mar 31, 2024 | -2.35 Mn |
| Dec 31, 2023 | -2.53 Mn |
| Sep 30, 2023 | -1.85 Mn |
| Jun 30, 2023 | -2.36 Mn |
| Mar 31, 2023 | -2.71 Mn |
| Dec 31, 2022 | -1.77 Mn |
| Sep 30, 2022 | -2.13 Mn |
| Jun 30, 2022 | -1.64 Mn |
| Mar 31, 2022 | -1.35 Mn |
| Dec 31, 2021 | -101,593.00 |
| Sep 30, 2021 | -541,113.00 |
| Jun 30, 2021 | -1.10 Mn |